TY - JOUR
T1 - Managing Crohn disease in children and adolescents
T2 - Focus on tumor necrosis factor antagonists
AU - Saeed, Shehzad A.
AU - Crandall, Wallace V.
PY - 2008
Y1 - 2008
KW - Adalimumab, therapeutic use
KW - Adolescents
KW - CDP 571, therapeutic use
KW - Certolizumab pegol, therapeutic use
KW - Children
KW - Crohn's disease, treatment
KW - Etanercept, therapeutic use
KW - Infliximab, therapeutic use
KW - Research and development
KW - Semapimod, therapeutic use
UR - https://www.scopus.com/pages/publications/37549047191
UR - https://www.scopus.com/inward/citedby.url?scp=37549047191&partnerID=8YFLogxK
U2 - 10.2165/00148581-200810010-00004
DO - 10.2165/00148581-200810010-00004
M3 - Review article
C2 - 18162006
AN - SCOPUS:37549047191
SN - 1174-5878
VL - 10
SP - 31
EP - 38
JO - Pediatric Drugs
JF - Pediatric Drugs
IS - 1
ER -